A newly formed pharmaceutical company was creating a novel cardiometabolic drug, a new small molecule, that was in Phase 2a testing in the United States and Canada. Renejix provided integrated development, manufacturing, and clinical supply solutions. Clinix Total Supply is an integrated method that integrates early-phase development with clinical supply production and distribution to shorten the road to the clinic. This complete method was implemented to enhance supply chain management and accelerate development schedules. This case study focuses on the problems encountered, the techniques used, and the results obtained via the deployment of an integrated development, manufacturing, and clinical supply solution.
Similar Posts
Small Molecule Analytical Services
This document provides both a high-level overview of Renejix’s stand-alone small molecule analytical services, and a detailed list of services organized by…
How to scale pharma manufacturing efficiently?
Pharmaceutical manufacturing is a complex journey. From the initial discovery of a potential drug to its eventual arrival in the hands of…
Comparator Sourcing, Branded or Generic Drug Sourcing
Using Renejix for your pharmaceutical needs means getting your supplies easily, anywhere, anytime, in perfect condition. Download
How to Overcome Challenges for Accelerated Drug Development
“New drugs receiving expedited approval have shorter timelines, which can create unique challenges for development and manufacturing. Joe Dukich, director of operations…
Streamlined Clinical Supply Services: RxReach Direct-to-Patient
Direct-to-Patient Clinical Supply Services: Amid the surge in remote clinical studies, the imperative of facilitating direct-to-patient distribution of clinical supplies has gained…
Mapping the Pathway to Designing Successful Treatments
Efficient, comprehensive transitions from early phase (preclinical up to phase 1) to late phase (phase 2 and beyond) are critical to the…